Literature DB >> 26544818

Fecal Incontinence: Community Prevalence and Associated Factors--A Systematic Review.

Kheng-Seong Ng1, Yogeesan Sivakumaran, Natasha Nassar, Marc A Gladman.   

Abstract

BACKGROUND: Fecal incontinence is a chronic and debilitating condition with significant health burden. Despite its clinical relevance, the prevalence of fecal incontinence remains inconsistently described.
OBJECTIVE: This study aimed to systematically review the literature regarding the prevalence of and factors associated with fecal incontinence among community-dwelling adults. DATA SOURCES: A search of the PubMed, Embase, and Cochrane databases was performed. STUDY SELECTION: Studies that reported the prevalence of fecal incontinence and/or associated factors in a community-based (ie, unselected) adult population were included. Two independent assessors reviewed eligible articles. MAIN OUTCOME MEASURES: Relevant data were extracted from each study and presented in descriptive form. The main outcome measures included the prevalence of fecal incontinence (adjusted and/or unadjusted), stratified for age and sex if reported; factors associated (and not associated) with fecal incontinence; and study quality, assessed using predefined criteria.
RESULTS: Of 3523 citations identified, 38 studies were included for review. The reported median prevalence of fecal incontinence was 7.7% (range, 2.0%-20.7%). Fecal incontinence equally affected both men (median, 8.1%; range, 2.3%-16.1%) and women (median, 8.9%; range, 2.0%-20.7%) and increased with age (15-34 years, 5.7%; >90 years, 15.9%). The study populations and diagnostic criteria used were heterogeneous, precluding any meaningful pooling of prevalence estimates. Study quality assessment revealed 6 high-quality studies, of which only 3 were performed in a representative sample. The median prevalence of fecal incontinence was higher in these studies at 11.2% (range, 8.3%-13.2%). The factors most commonly reported to be associated with fecal incontinence included increasing age, diarrhea, and urinary incontinence. LIMITATIONS: Heterogeneity of studies precluded meaningful pooling or meta-analysis of data.
CONCLUSIONS: Fecal incontinence is a prevalent condition of equal sex distribution, affecting ≈1 in 8 community adults, and has identifiable associated factors. The paucity of high-quality prevalence studies emphasizes the need for future population-based studies that use standardized diagnostic criteria for fecal incontinence.

Entities:  

Mesh:

Year:  2015        PMID: 26544818     DOI: 10.1097/DCR.0000000000000514

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  34 in total

1.  Prevalence of Fecal Incontinence in Adults with Cystic Fibrosis.

Authors:  Alban Benezech; Nadine Desmazes-Dufeu; Karine Baumstarck; Michel Bouvier; Bérengère Coltey; Martine Reynaud-Gaubert; Véronique Vitton
Journal:  Dig Dis Sci       Date:  2017-10-30       Impact factor: 3.199

2.  Towards a more scientific approach to measuring barriers to seeking health care in women with fecal incontinence: the BCABL questionnaire.

Authors:  Diaa E E Rizk
Journal:  Int Urogynecol J       Date:  2017-02-10       Impact factor: 2.894

3.  Adverse events of sacral neuromodulation for fecal incontinence reported to the federal drug administration.

Authors:  Klaus Bielefeldt
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

4.  Fecal Incontinence: Epidemiology, Impact, and Treatment.

Authors:  Katarzyna Bochenska; Anne-Marie Boller
Journal:  Clin Colon Rectal Surg       Date:  2016-09

5.  Sacral neuromodulation for fecal incontinence in Latin America: initial results of a multicenter study.

Authors:  L Oliveira; G Hagerman; M L Torres; C M Lumi; J A C Siachoque; J C Reyes; J Perez-Aguirre; J C Sanchez-Robles; V H Guerrero-Guerrero; S M Regadas; V G Filho; G Rosato; E Vieira; L Marzan; D Lima; E Londoño-Schimmer; S D Wexner
Journal:  Tech Coloproctol       Date:  2019-06-12       Impact factor: 3.781

6.  Controlling faecal incontinence in women by performing anal exercises with biofeedback or loperamide: a randomised clinical trial.

Authors:  J Eric Jelovsek; Alayne D Markland; William E Whitehead; Matthew D Barber; Diane K Newman; Rebecca G Rogers; Keisha Dyer; Anthony G Visco; Gary Sutkin; Halina M Zyczynski; Benjamin Carper; Susan F Meikle; Vivian W Sung; Marie G Gantz
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-07-15

7.  Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause.

Authors:  Kyle Staller; Mary K Townsend; Hamed Khalili; Raaj Mehta; Francine Grodstein; William E Whitehead; Catherine A Matthews; Braden Kuo; Andrew T Chan
Journal:  Gastroenterology       Date:  2017-02-14       Impact factor: 22.682

8.  Outcomes of GatekeeperTM prosthesis implantation for the treatment of fecal incontinence: a multicenter observational study.

Authors:  Loris Trenti; Sebastiano Biondo; Fernando Noguerales; Jesus Nomdedeu; Alba Coret; Roland Scherer; Domenico Fraccalvieri; Riccardo Frago; Esther Kreisler
Journal:  Tech Coloproctol       Date:  2017-11-20       Impact factor: 3.781

9.  Fecal incontinence after transanal endoscopic microsurgery.

Authors:  Matas Jakubauskas; Valdemaras Jotautas; Eligijus Poskus; Saulius Mikalauskas; Gintare Valeikaite-Tauginiene; Kestutis Strupas; Tomas Poskus
Journal:  Int J Colorectal Dis       Date:  2018-02-22       Impact factor: 2.571

Review 10.  Biofeedback for Pelvic Floor Disorders.

Authors:  Melissa Hite; Thomas Curran
Journal:  Clin Colon Rectal Surg       Date:  2020-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.